Nevertheless, a recent evaluation of transcriptomic glioma datasets from The Cancer Genome Atlas (TCGA) revealed a direct association of high FGFR4 expression and dismal prognosis, progressively upregulated in recurrent tumors. Here, FGFR4 is linked to central nervous system cancer.